Acorda is a biotechnology company developing and commercializing neurology therapies for Parkinson’s disease, migraine and multiple sclerosis
Total raised: $30M
Investors 2
| Date | Name | Website |
| - | 5AM Ventur... | 5amventure... |
| - | Vivo Capit... | vivocapita... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 12.10.2010 | Series C | $30M | - | 5amventure... |
Mentions in press and media 3
| Date | Title | Description | Source |
| 29.06.2016 | The biotech IPO feast flags as investors lose their appeti... | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. B... | endpts.com... |
| 12.10.2010 | SYNOSIA THERAPEUTICS RAISES $30M IN SERIES C FINANCING | - | 5amventure... |
| 12.10.2010 | Synosia Therapeutics Raises $30M in Series C Financing | Synosia Therapeutics, a Basel, Switzerland-based biotherapeutics company focused on neurology and ps... | finsmes.co... |